While exact drug-specific discounts are confidential, researchers have estimated discounts of roughly 52% off list price generally
Retatrutide (LY3437943) is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously that has not received UK marketing authorisation from the MHRA or approval from the EMA
The Risks of Using Glutathione for Skin Lightening Glutathione may cause health complications if used improperly or for an extended period
Patents are legal mechanisms designed to promote innovation by giving pharmaceutical companies exclusive rights to sell their drugs without competition for a specified period (usually 17 and a half years)
Injection site and any recent changes in your routine (new soap, detergent, etc.)
If you want to understand the medication journey from start to finish, this guide to getting GLP-1 prescribed explains the process clearly